A Pilot Pharmacodynamic/Pharmacokinetic Study of SalmeterolXinofoate as a Dry Powder in Combination with Fluticasone in Patients with Asthma for Dose-Scale Bronchodilator Model Development.
Latest Information Update: 20 Jun 2011
Price :
$35 *
At a glance
- Drugs Salmeterol/fluticasone propionate (Primary)
- Indications Asthma
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Oriel Therapeutics
- 20 Jun 2011 New trial record